Prominex develops molecular diagnostic assays for Point-of-Care infectious disease testing, providing accurate results in just five minutes. Their technology enables individuals to perform rapid and affordable tests for respiratory infections at home, enhancing accessibility and efficiency in disease detection.
Funding
$25.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional laboratory-based molecular diagnostic tests for infectious diseases often require specialized equipment, trained personnel, and long turnaround times, limiting accessibility and delaying treatment decisions. Point-of-care testing options are often less accurate or require complex sample preparation steps.
Solution
Prominex is developing rapid, point-of-care molecular diagnostic assays for infectious disease testing, delivering accurate results in approximately five minutes. The assays are designed to be easy to use, affordable, and scalable, enabling individuals to perform testing at home or in decentralized settings. The technology aims to improve accessibility to rapid and accurate diagnostics, facilitating timely detection and management of infectious diseases. The assays are designed to be reusable and multiplex, allowing for the simultaneous detection of multiple pathogens.
Target Audience
The primary target audience includes individuals seeking convenient at-home testing options, healthcare providers needing rapid point-of-care diagnostics, and public health organizations aiming to improve disease surveillance and control.
Features
- Rapid molecular diagnostic testing with results in approximately 5 minutes
- Easy-to-use format suitable for at-home or point-of-care testing
- Affordable testing solution for increased accessibility
- Reusable assay components for cost-effectiveness
- Multiplex capabilities for simultaneous detection of multiple pathogens
- Scalable manufacturing process for high-volume production